RxDoctor Payments Data

Chih Cheng, MD

Dermatology · Apex, NCNPI 1316010861

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 24.5% of the total. That places this record below the midpoint for dermatology clinicians in NC, where the typical reported total is $2,057.

$469in general payments, 2019–2025

Across 33 payments — averaging $14.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$115
  • LEO Pharma Inc.$113
  • UCB, Inc.$74
  • Novartis$60
  • Johnson & Johnson$57
  • Sanofi$37
  • plus $12 from 1 others
$100,000in ownership & investment interests, 2019–2025

Across 1 payment — averaging $100,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Modmed Procure LLC$100K

What the payments were for

  • Food & beverage$469100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie6$115
LEO Pharma Inc.14$113
UCB, Inc.3$74
Novartis3$60
Johnson & Johnson4$57
Sanofi2$37
Prugen, Inc. Pharmaceuticals1$12

How this compares

$469 in reported general payments places this provider in the 25th percentile of 475 dermatology providers in North Carolina.

See all dermatology providers in North Carolina

Medicare billing

Part B allowed, 2024
$14,734
Medicare patients
48
Services billed
217

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ketoconazole15$227

Paid to pharmacies, not to this prescriber.

Other dermatology in Apex

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →